Literature DB >> 8827065

Familial Wilms' tumor: a descriptive study.

N E Breslow1, J Olson, J Moksness, J B Beckwith, P Grundy.   

Abstract

Among 6,209 patients with Wilms' tumor entered on the National Wilms' Tumor Study (NWTS), 93 patients (1.5%) from 63 families had a positive family history. In 30 of these 63 families a (half) sibling or parent of the NWTS patient was confirmed to have had Wilms' tumor. Fifteen (16.1%) of the familial, but only 7.1% of sporadic cases, had bilateral disease. Mean ages at diagnosis were 15.8 vs. 35.2 months (P = 0.012) for bilateral vs. unilateral familial cases and 32.0 vs. 44.7 months for sporadic cases. Intralobar nephrogenic rests were found twice as frequently in association with the tumors of familial as with those of sporadic cases. Cases of bilateral and metastatic disease tended to cluster within specific families, suggesting heterogeneity in the genetic etiology. The number and age distribution of familial cases transmitted through the father were about the same as those of cases transmitted through the mother. This finding is inconsistent with models of genomic imprinting that involve familial transmission of a tumor-suppressor gene and it casts further doubt on the hypothesis that all bilateral cases are hereditary.

Entities:  

Mesh:

Year:  1996        PMID: 8827065     DOI: 10.1002/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  21 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Parental age and childhood cancer risk: A Danish population-based registry study.

Authors:  Zuelma A Contreras; Johnni Hansen; Beate Ritz; Jorn Olsen; Fei Yu; Julia E Heck
Journal:  Cancer Epidemiol       Date:  2017-07-14       Impact factor: 2.984

Review 3.  Wilms' tumour: a complex enigma to decipher.

Authors:  María José Robles-Frías; Michele Biscuola; María Angeles Castilla; María Angeles López-García; Felicia Sánchez-Gallego; José Palacios
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

4.  Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

Authors:  A K Charles; K W Brown; P J Berry
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.

Authors:  A K Charles; S Mall; J Watson; P J Berry
Journal:  Mol Pathol       Date:  1997-06

Review 6.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.

Authors:  R H Scott; L Walker; Ø E Olsen; G Levitt; I Kenney; E Maher; C M Owens; K Pritchard-Jones; A Craft; N Rahman
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

Review 7.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

8.  Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.

Authors:  Barbara Guertl; Ivo Leuschner; Dieter Harms; Gerald Hoefler
Journal:  Virchows Arch       Date:  2006-05-20       Impact factor: 4.064

9.  Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.

Authors:  Timothy Blake Palculict; E Cristy Ruteshouser; Yu Fan; Wenyi Wang; Louise Strong; Vicki Huff
Journal:  J Med Genet       Date:  2015-11-13       Impact factor: 6.318

10.  MYC gene associated polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study.

Authors:  Jiabin Liu; Rui-Xi Hua; Wen Fu; Jinhong Zhu; Wei Jia; Jiao Zhang; Haixia Zhou; Jiwen Cheng; Huimin Xia; Guochang Liu; Jing He
Journal:  Ann Transl Med       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.